Agenus | AGEN - Selling And Administration Expenses

Agenus reported $25.04M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.21B 4M
Agenus AGEN:US USD 25.04M 6.93M
Amgen AMGN:US USD 1.47B 181M
AstraZeneca AZN:LN USD 3.53B 174M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Celldex Therapeutics CLDX:US USD 6.6M 68K
CSL CSL:AU USD 1.15B 251.7M
Dynavax Technologies DVAX:US USD 30.38M 1.22M
Eli Lilly And LLY:US USD 1.64B 29M
Gilead Sciences GILD:US USD 2.02B 807M
GlaxoSmithKline GSK:LN GBP 2.44B 467M
Glaxosmithkline GSK:US GBP 2.44B 467M
Immunogen IMGN:US USD 42.06M 8.44M
Intrexon XON:US USD 11.51M 1.37M
Jiangsu Hengrui Me. 600276:CH CNY 2.37B 415.39M
Johnson & Johnson JNJ:US USD 6.51B 423M
Karyopharm Therapeutics KPTI:US USD 34.65M 4K
Macrogenics MGNX:US USD 13.67M 1.68M
Merck MRK:GR EUR 1.57B 19M
Merk MRK:US USD 2.63B 134M
Northwest Biotherapeutics NWBO:US USD 8.13M 199K
Novartis NOVN:VX USD 3.7B 295M
Novavax NVAX:US USD 161.66M 38.79M
Pfizer PFE:US USD 4.87B 1.33B
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Rigel Pharmaceuticals RIGL:US USD 32.17M 6.28M
Sangamo Biosciences SGMO:US USD 16.44M 205K
Veracyte VCYT:US USD 41.69M 1.04M
YTE INCY:US USD 272.82M 6.36M